Prosecution Insights
Last updated: August 18, 2026

Examiner: LE, QUYNH DAO

Tech Center 3700 • Art Units: 3781

This examiner grants 33% of resolved cases

Performance Statistics

33.3%
Allow Rate
-36.7% vs TC avg
85
Total Applications
+6.5%
Interview Lift
1275
Avg Prosecution Days
Based on 45 resolved cases, 2023–2026

Rejection Statute Breakdown

2.5%
§101 Eligibility
13.3%
§102 Novelty
64.2%
§103 Obviousness
18.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17503188 TRANSCAVAL VENTURI Non-Final OA Edwards Lifesciences Corporation
18104750 SYSTEMS AND METHODS FOR AUTOMATIC BIDIRECTIONAL PRIMING OF A GAS-ENRICHMENT SYSTEM Non-Final OA Zoll Circulation, Inc.
18255950 MEMBRANE GAS EXCHANGER Final Rejection FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
18855709 Automated Syringe Non-Final OA Becton, Dickinson and Company
18885880 Closed-System Infusion Adapter with Simplified Connection Mechanism Non-Final OA Becton, Dickinson and Company
17809083 ODOR TREATMENT FOR A URINE COLLECTION SYSTEM Non-Final OA PureWick Corporation
18547969 PHOTO-ECMO APPARATUS, SYSTEMS, AND METHODS Non-Final OA The General Hospital Corporation
18920829 THERAPEUTIC PLASMA EXCHANGE METHODS AND APHERESIS KIT FOR FLUSH AND DIVERT PRIME STAGE WHEN USING AN ADSORPTION COLUMN Non-Final OA Fenwal, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month